An observational study in Inflammation and Chronic Kidney Disease, sponsored by Haseki Training and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 16 Years to 80 Years. Per ClinicalTrials.gov, last updated 2011-07-20.
Sponsored by Haseki Training and Research Hospital · Observational
The aim of the study is to measure Pentraxin-3 levels in patients on hemodialysis, peritoneal dialysis and those in the pre-dialysis period; and to compare these groups with the control group; so as to investigate the eligibility of it as a reliable marker of inflammation; relationship with other inflammatory markers and carotis intima media thickness.
The investigators planned to involve four group of patients: Hemodialysis, peritoneal dialysis, pre-dialysis and the control group; with about 25 patients planned to be involved in each group. The laboratory parameters to be measured are Pentraxin-3, C-reactive protein (CRP), high sensitive CRP, fibrinogen and interleukin-6. Concomitantly, carotis intima media thickness will be measured in the radiology clinic. Statistical analysis will be carried on by Statistical Package for Social Sciences (SPSS) for Windows 13.0. The variables acting on the inflammatory parameters and the correlation between them and carotis intima media thickness will be studied.
3,840 studies on the registry are indexed under Kidney Diseases; 500 are open to participants now.
This study's planned enrollment of 85 is below the median of 192 across 1,033 observational studies indexed under Kidney Diseases.
Browse Kidney Diseases studies →Haseki Training and Research Hospital is the lead sponsor of 75 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients will be selected among those who are followed up in our clinic.
Exclusion Criteria:
Patients on chronic hemodialysis program
Patients on chronic peritoneal dialysis program
Patients with chronic kidney disease stage-4
Healthy subjects
Pentraxin-3 level
Pentraxin-3 level will be compared with other inflammatory markers.
Time frame: Five months
Carotis intima media thickness
Correlation of Pentraxin-3 and carotis intima media thickness
Time frame: Five months
This study is completed, as verified in Jul 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Haseki Training and Research Hospital